drugset / Trial / NCT03236883
Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Pancreatic Cancer
Non-randomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the safety and efficacy of non-myeloablative hematopoietic stem cell transplantation in the treatment of pancreatic cancer.
Timeline
- Start
- 2016-04
- Primary completion
- 2019-04
- Completion
- 2019-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GPBSC | Unknown | 2e+08 cells/kg | — |
| Subject | GPBSC | Unknown | 3e+08 cells/kg | — |
| Background | Gemcitabine | Small molecule | 1000 mg/m2 | Intravenous |